Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Linezolid for Oral Suspension

Approval Number

国药准字H20253003

Company浙江普利药业有限公司

Registration Date

January 2, 2025

Drug Information

Generic Name

利奈唑胺干混悬剂

Dosage Form

口服混悬剂

Strength

3g（按C₁₆H₂₀FN₃O₄计）

Drug Type

化学药品

Registration Date

January 2, 2025

Company Information

Applicant Company

Company Name浙江普利药业有限公司

Company Address

浙江省杭州市临平区经济开发区新洲路78号

Manufacturing Company

Company Name浙江普利药业有限公司

Company Address

浙江省杭州市临平区经济开发区新洲路78号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

利奈唑胺干混悬剂 - NMPA 批准文号 | MedPath